Search alternatives:
point decrease » point increase (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a point » _ point (Expand Search), 5 point (Expand Search), _ points (Expand Search)
point decrease » point increase (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a point » _ point (Expand Search), 5 point (Expand Search), _ points (Expand Search)
-
75701
Glucose metabolism defects in <i>pex</i> mutant flies.
Published 2017“…Glycogen intermediates are also reduced in the <i>pex</i> mutant flies (with the exception of maltohexaose in the <i>pex16</i> mutants). A number of pentose phosphate intermediates such as ribulose 5- phosphate, xylulose 5-phosphate and mannose 6-phosphate are also reduced. …”
-
75702
Cytokines altered by Rolipram administration after spinal cord injury.
Published 2013“…<p>A cytokine protein array (RayBiotech Inc.) was used to identify changes in the production of 19 cytokines after SCI and/or vehicle or Rolipram administration. …”
-
75703
Table_1_The impact of China's zero markup drug policy on drug costs for managing Parkinson's disease and its complications: an interrupted time series analysis.docx
Published 2023“…Outpatient (β<sub>1</sub> = −201.7, 95%CI: −285.4, −117.9) and inpatient (β<sub>1</sub> = −372.1, 95% CI: −643.6, −100.6) drug costs for managing PD significantly decreased when implementing ZMDP. However, for outpatients without health insurance, the trend change in drug costs for managing PD (β<sub>2</sub> = 16.8, 95% CI: 8.0, 25.6) or PD complications (β<sub>2</sub> = 12.6, 95% CI: 5.5, 19.7) significantly increased. …”
-
75704
DataSheet_1_Associations of chest X-ray trajectories, smoking, and the risk of lung cancer in two population-based cohort studies.docx
Published 2023“…However, the associations of CXR trajectories, smoking and LC risk remain unknown.</p>Methods<p>A total of 52,486 participants from the PLCO and 22,194 participants from the NLST were included. …”
-
75705
-
75706
-
75707
-
75708
-
75709
-
75710
-
75711
-
75712
-
75713
The stabilising effect of presynaptic inhibition is robust to details of the transfer function.
Published 2020“…<p>We qualitatively recover the results obtained for linear transfer functions if the release probability decreases exponentially or as a sigmoid with increasing inhibitory rate. …”
-
75714
-
75715
Perturbation of <i>Gata1</i> regulatory dynamics impacts frequency of commitment <i>in silico</i> and <i>in vitro</i>.
Published 2013“…High probability of commitment peaks are more frequent than in wild type simulations (<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1003197#pcbi-1003197-g005" target="_blank">Figure 5A</a>). …”
-
75716
Network pharmacology-based screening of active constituents of <i>Avicennia marina</i> and their clinical biochemistry related mechanism against breast cancer
Published 2023“…Additionally, a molecular docking study demonstrates that active drugs have a higher affinity for the target that may be used to decrease breast cancer. …”
-
75717
p62 levels in Atg mutants, p62 RNAi and p62 overexpression cells.
Published 2012“…Scalebar in panel B equals 30 µm for panels B–E. <i>Genotypes are: (A) lane 1: w [1118], lane 2: Atg7[d77]/Atg7[d14], lane 3: Atg8a[d4], lane 4: UbiGal4/+; p62[HMS00551]/+, lane 5: UbiGal4/+; p62[HMS00938]/+, lane 6: w [1118], lane 7: Atg8a[d4], lane 8: cgGal4/UAS-p62-GFP; (B) hs-Flp; UAS-LampGFP/p62[KK108193]; Act>CD2>Gal4, UAS-Dcr2/+; (C) hs-Flp; UAS-LampGFP/+; Act>CD2>Gal4, UAS-Dcr2/p62[HMS00551]; (D) hs-Flp; UAS-LampGFP/+; Act>CD2>Gal4, UAS-Dcr2/p62[HMS00938]; (E) hsFlp; UAS-p62-GFP/+; Act>CD2>Gal4,UAS-Dcr2/+.…”
-
75718
Results from test runs in four different conditions.
Published 2021“…<p>All five barcode factors (A), two factors (GCC and HD; B), one factor (GCC; C) and another single factor (HD; D) were considered in the conditions for selecting an optimal barcode set in each condition. …”
-
75719
Impact of alternative assumptions on life expectancy.
Published 2010“…Depending on the baseline CD4 cell count, life-expectancy was increased by 14.8 to 30.9 months with no late failure (green), and was decreased by 2.8 to 6.6 months with 1.5-fold increase in late failure (orange), and by 5.1 to 11.0 months with a 2-fold increase in late failure (red). …”
-
75720